Peg-Ifn Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471AM1)(COMPLETED) - Related Studies

Peg-Ifn Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471AM1)(COMPLETED)

This study has been completed.

Study NCT00081770. Last updated on December 20, 2007. Information provided by Schering-Plough

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Hepatitis C, Chronic

2	Additional conditions recognized in this trial
		Hepatitis
		Hepatitis C
		Hepatitis, Chronic

3	More general conditions related to this trial
		Digestive System Diseases
		Flaviviridae Infections
		Hepatitis, Viral, Human
		Liver Diseases
		RNA Virus Infections
		Virus Diseases

4	Interventions listed in this trial
		peginterferon alfa-2b (SCH 54031)
		ribavirin (SCH 18908)
		peginterferon alfa-2a
		ribavirin

5	Additional drug interventions recognized in this trial
		Interferon Alfa-2b
		Peginterferon alfa-2b

6	More general drug interventions related to this trial
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Anti-Infective Agents
		Antimetabolites
		Antineoplastic Agents
		Antiviral Agents
		Growth Inhibitors
		Growth Substances
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		Schering-Plough